Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OSTX
STRONG SELLOS Therapies Incorporated · Healthcare · United States · $68M · Avg Vol: $1M/d
16
StockRankGet insider-trade alerts
Q
15
V
25
M
57
P/E (TTM)
—
ROE
—
D/E
—
Dividend %
—
Loading 1Y...
PRICE (1Y)-10.0%
SMA 50SMA 200
Close
$1.53
RSI (14)
46.5
52W High
$2.57
From 52W High
0.6%
SCORE BREAKDOWN
Quality
15
ROIC (ROA)
-366.6%*0.9
ROE
—N/A
GP/Assets
—N/A
Op. Margin
0.0%41.3
FCF/Assets
-215.0%0.5
Piotroski
111.4
Int. Cover
-50.0x6.3
D/E Ratio
—N/A
Current Ratio
0.05x0.1
Value
25
P/E (TTM)
—N/A
EV/EBITDA
-2.1x25.0
P/FCF
—N/A
P/B
-5.5x25.0
P/S
—N/A
Div Yield
—N/A
Momentum
57
52W High %
60%38.8
RS 6M
-4%69.2
SMA 50/200
1.08x78.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+134%80.5
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$68M
P/E (Forward)
4.2x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OSTX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OSTX | OS Therapies Incorporated(you) | $68M | 16 | STRONG SELL |
| ACRV | Acrivon Therapeutics, Inc. | $68M | 14 | STRONG SELL |
| PLRX | Pliant Therapeutics, Inc. | $67M | 18 | STRONG SELL |
| MNOV | MediciNova, Inc. | $65M | 14 | STRONG SELL |
| VRCA | Verrica Pharmaceuticals Inc. | $86M | 16 | STRONG SELL |
| FLNA | Filana Therapeutics, Inc. | $58M | 13 | STRONG SELL |
| IMA | ImageneBio, Inc. | $63M | 11 | STRONG SELL |
| MAIA | MAIA Biotechnology, Inc. | $75M | 12 | STRONG SELL |
| CING | Cingulate Inc. | $62M | 11 | STRONG SELL |
| ACET | Adicet Bio, Inc. | $73M | 21 | SELL |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%